Cardiovascular Intervention and Therapeutics最新文献_第4页

Intra-aortic balloon pump is associated with the lowest whereas Impella with the highest inpatient mortality and complications regardless of severity or hospital types. 无论病情严重程度或医院类型如何，主动脉内球囊泵的相关死亡率最低，而 Impella 的相关住院死亡率和并发症最高。

IF 3.2

Cardiovascular Intervention and Therapeutics Pub Date : 2024-07-01 Epub Date: 2024-03-31 DOI: 10.1007/s12928-024-00993-8

Mohammad Reza Movahed, Armin Talle, Mehrtash Hashemzadeh

{"title":"Intra-aortic balloon pump is associated with the lowest whereas Impella with the highest inpatient mortality and complications regardless of severity or hospital types.","authors":"Mohammad Reza Movahed, Armin Talle, Mehrtash Hashemzadeh","doi":"10.1007/s12928-024-00993-8","DOIUrl":"10.1007/s12928-024-00993-8","url":null,"abstract":"Impella and intra-aortic balloon pumps (IABP) are commonly utilized in patients with cardiogenic shock. However, the effect on mortality remains controversial. The goal of this study was to evaluate the effect of Impella and IABP on mortality in patients with cardiogenic shock the large Nationwide Inpatient Sample (NIS) database was utilized to study any association between the use of IABP or Impella on outcome. ICD-10 codes for Impella, IABP, and cardiogenic shock for available years 2016-2020 were utilized. A total of 844,020 patients had a diagnosis of cardiogenic shock. A total of 101,870 patients were treated with IABP and 39645 with an Impella. Total inpatient mortality without any device was 34.2% vs only 25.1% with IABP use (OR = 0.65, CI 0.62-0.67) but was highest at 40.7% with Impella utilization (OR = 1.32, CI 1.26-1.39). After adjusting for 47 variables, Impella utilization remained associated with the highest mortality (OR: 1.33, CI 1.25-1.41, p < 0.001), whereas IABP remained associated with the lowest mortality (OR: 0.69, CI 0.66-0.72, p < 0.001). Separating rural vs teaching hospitals revealed similar findings. In patients with cardiogenic shock, the use of Impella was associated with the highest whereas IABP was associated with the lowest in-hospital mortality regardless of comorbid condition.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140329597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How to evacuate when Sapien3 transcatheter heart valve cannot pass through a severely calcified aortic valve. 当 Sapien3 经导管心脏瓣膜无法通过严重钙化的主动脉瓣时，如何进行排空。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-07-01 Epub Date: 2024-01-16 DOI: 10.1007/s12928-023-00980-5

Yasuyuki Tsuchida, Hideyuki Kawashima, Ken Kozuma, Yusuke Watanabe

引用次数: 0

A novel method to achieve enhanced and optimal commissural alignment during transcatheter aortic valve implantation. 在经导管主动脉瓣植入术中实现增强和最佳会厌对齐的新方法。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-07-01 Epub Date: 2024-03-16 DOI: 10.1007/s12928-024-00991-w

Takuya Tominaga, Yasuhiro Ichibori, Satoshi Nakawatase, Naoki Mori, Tomohiko Sakamoto, Toru Kuratani, Yoshiki Sawa, Yoshiharu Higuchi

引用次数: 0

Radial artery avulsion: case report of a rare complication in interventional cardiology. 桡动脉撕脱：介入心脏病学中罕见并发症的病例报告。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-07-01 Epub Date: 2024-03-15 DOI: 10.1007/s12928-023-00982-3

Sophia El Harrouchi, Arthur Ramonatxo, Valentin Patouiller, Sébastien Levesque

引用次数: 0

A novel finding for predicting heightened risk for vessel injury caused by debulking devices. 一项新发现，可用于预测去骨器造成血管损伤的高风险。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-06-24 DOI: 10.1007/s12928-024-01024-2

Hidenari Matsumura, Kenichiro Shimoji, Nobuhiro Yoshijima

引用次数: 0

Impending rupture of giant iliac artery psedoaneurysm after endovascular repair with coil embolization and stent grafts. 用线圈栓塞和支架移植物进行血管内修复后，巨大髂动脉脓动脉瘤即将破裂。

IF 3.2

Cardiovascular Intervention and Therapeutics Pub Date : 2024-06-20 DOI: 10.1007/s12928-024-01019-z

Yuki Matsumoto, Yuya Oshikiri, Hidemi Morioka, Yoshihiro Morino

引用次数: 0

Successful percutaneous coronary intervention using intravascular lithotripsy with intravascular ultrasound and optical coherence tomography guidance for a calcified saphenous vein graft. 使用血管内碎石术在血管内超声和光学相干断层扫描引导下成功对钙化的大隐静脉移植物进行经皮冠状动脉介入治疗。

IF 3.2

Cardiovascular Intervention and Therapeutics Pub Date : 2024-06-18 DOI: 10.1007/s12928-024-01021-5

Yohei Numasawa, Kei Kamata, Tadafumi Tamura, Souichi Yokokura, Hidenori Kojima, Makoto Tanaka

引用次数: 0

No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis. 急性心肌梗死中无标准可改变的心血管风险因素：发病率、病理生理学和预后。

IF 3.2

Cardiovascular Intervention and Therapeutics Pub Date : 2024-06-17 DOI: 10.1007/s12928-024-01022-4

Yuichi Saito, Kenichi Tsujita, Yoshio Kobayashi

引用次数: 0

Adverse clinical events after percutaneous coronary intervention in very elderly patients with acute coronary syndrome. 高龄急性冠状动脉综合征患者经皮冠状动脉介入治疗后的不良临床事件。

IF 3.2

Cardiovascular Intervention and Therapeutics Pub Date : 2024-06-05 DOI: 10.1007/s12928-024-01020-6

Takanori Kawamoto, Hisao Otsuki, Hiroyuki Arashi, Kentaro Jujo, Toshiaki Oka, Fumiaki Mori, Hiroyuki Tanaka, Tomohiro Sakamoto, Yasuhiro Ishii, Yutaka Terajima, Masahiro Yagi, Atsushi Takagi, Shoji Haruta, Junichi Yamaguchi

{"title":"Adverse clinical events after percutaneous coronary intervention in very elderly patients with acute coronary syndrome.","authors":"Takanori Kawamoto, Hisao Otsuki, Hiroyuki Arashi, Kentaro Jujo, Toshiaki Oka, Fumiaki Mori, Hiroyuki Tanaka, Tomohiro Sakamoto, Yasuhiro Ishii, Yutaka Terajima, Masahiro Yagi, Atsushi Takagi, Shoji Haruta, Junichi Yamaguchi","doi":"10.1007/s12928-024-01020-6","DOIUrl":"https://doi.org/10.1007/s12928-024-01020-6","url":null,"abstract":"The number of very elderly patients with acute coronary syndrome (ACS) is increasing. Therefore, owing to the need for evidence-based treatment decisions in this population, this study aimed to examine the clinical outcomes during 1 year after percutaneous coronary intervention (PCI) in very elderly patients with ACS. This prospective multicenter observational study comprised 1337 patients with ACS treated with PCI, classified into the following four groups according to age: under 60, <60 years; sexagenarian, ≥60 and <69 years; septuagenarian, ≥70 and <80 years; and very elderly, ≥80 years. The primary endpoint was a composite of the first occurrence of all-cause death, nonfatal myocardial infarction, nonfatal stroke, and bleeding within 1 year after PCI. We used the sexagenarian group as a reference and compared outcomes with those of the other groups. The incidence of the primary endpoint was significantly higher in the very elderly group than in the sexagenarian group (36 [12.7%] vs. 24 [6.9%], respectively; hazard ratio, 1.94; 95% confidence interval: 1.16-3.26; p = 0.012). The higher incidence of the primary endpoint was primarily driven by a higher incidence of all-cause death. When the multivariable analysis was used to adjust for patient characteristics and comorbidities, no difference was observed in the primary endpoint between the very elderly and sexagenarian groups (p = 0.96). The incidence of adverse events after PCI, particularly all-cause death, in very elderly patients with ACS was high. However, if several confounders are adjusted, comparable outcomes may be expected within 1 year after PCI among this population.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141261114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Indications and outcomes of the MitraClip G4 device with controlled gripper actuation system. MitraClip G4 装置的适应症和疗效，带可控夹持器驱动系统。

IF 3.2

Cardiovascular Intervention and Therapeutics Pub Date : 2024-06-04 DOI: 10.1007/s12928-024-01018-0

Naoki Nishiura, Shunsuke Kubo, Mikitaka Fujita, Kazunori Mushiake, Sachiyo Ono, Kohei Osakada, Takeshi Maruo, Kazushige Kadota

{"title":"Indications and outcomes of the MitraClip G4 device with controlled gripper actuation system.","authors":"Naoki Nishiura, Shunsuke Kubo, Mikitaka Fujita, Kazunori Mushiake, Sachiyo Ono, Kohei Osakada, Takeshi Maruo, Kazushige Kadota","doi":"10.1007/s12928-024-01018-0","DOIUrl":"https://doi.org/10.1007/s12928-024-01018-0","url":null,"abstract":"The MitraClip G4 device has controlled gripper actuation (CGA) system, which allows the anterior and posterior grippers operate separately in transcatheter edge-to-edge repair (TEER). We investigated the indications and outcomes of the use of CGA system during TEER for significant mitral regurgitation (MR). We reviewed 158 patients undergoing TEER with MitraClip G4 from September 2020 to July 2023. The CGA indications were: (1) for grasping and (2) for leaflet insertion confirmation. Leaflet grasping was completed with CGA in 18 patients (11 and 7 patients for grasping and leaflet insertion confirmation, respectively). Patients with flail leaflets or coaptation gap more frequently required CGA, indicating more complex mitral valve anatomy. The procedural success and adverse event rates (death, leaflet tear and single leaflet device attachment) were not different between the CGA and non-CGA groups. In patients requiring CGA, single leaflet device attachment was observed in 1 patient and leaflet tear in 1 patient during follow-up. In these two cases, CGA was required for grasping, and the clip was moved over a large distance (6.5 and 12.4 mm, respectively). In patients who had undergone CGA for confirmation, no device-related adverse event or MR recurrence was noted. In patients with complex mitral valve anatomy, CGA may be a safe and effective method for confirming leaflet insertion. It should be noted that when using CGA for leaflet grasping, especially when the clip is moved significantly, attention should be paid to leaflet adverse events.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141236860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0